You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Successfully

Similar documents
Wednesday, March 16, 2016

HPV Cancer Prevention

You are the Key to HPV Cancer Prevention

Dr. Sarah Oliver, MD Pediatrics Rockcastle Regional Hospital July 22, 2016

You are the Key to HPV Cancer Prevention

HPV FREE IDAHO. Fundamentals of HPV Bill Atkinson, MD MPH

Evidence-Based HPV Disease Prevention HPV VACCINE

Overview of HPV; Making it Real

Selling Parents on HPV Vaccination for Their Preteens: You Are The Key

Objectives. Selling Parents on HPV Vaccination for Their Preteens: You Are The Key. HPV Facts TOP TEN List. Disclosure

HPV Summit: Wisconsin

Making the connections Washington families need to be healthy. Preventing HPV Cancers: A Distance-Learning Course in Washington

BUST MYTHS WITH FACTS

Raising HPV Immunization Rates Through Provider Education. Objectives HPV INFECTION & DISEASE 8/2/2018. Understanding the Burden

Cervical Cancer The Role of Primary Care in Reducing Cancer Disparities

The mission of the American School Health Association is to transform all schools into places where every student learns and thrives.

HPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION

You are the Key to HPV Cancer Prevention Presentation Script

You are the Key to HPV Cancer Prevention Communicating about HPV Vaccination

BUST MYTHS WITH FACTS

QC for Kids Lunch and Learn Webinar: HPV-related Cancer Prevention in Maine

HPV-Associated Disease and Prevention

Human Papillomavirus (HPV): Vaccine-Preventable Disease

Improving HPV Vaccine Coverage Why We Must and How We Can Do Better

Speaker Name Speaker Title Speaker Affiliation. {Updated August 5, 2014; Replace with date of Presentation}

The Importance of HPV Vaccination and Strategies to Increase Uptake in Pediatric & Family Practices

The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California

You are the Key to HPV Cancer Prevention

9/11/2018. HPV Yoga. Human Papillomavirus. Human Papillomavirus (HPV) Disease. Most common sexually transmitted infection in the U.S.

HPV Free ID. Toolkit for Increasing HPV Vaccination Rates in Idaho. Toolkit for Increasing HPV Vaccination

Practical Strategies to Protect our Community from HPV-related Cancers.

12/4/18 HPV VACCINATION IN MASSACHUSETTS AND BEYOND VANUCCI DISCLOSURE OBJECTIVES VACCINE BENEFITS VACCINE COMMUNICATION WORLD

in the United States during the period ACIP to routinely receive HPV vaccination.

HPV - From Warts to Cancer

2017 Human Papillomavirus Immunisation Programme

Disclosures. Human Papillomaviruses. Objectives. The Second Cancer Vaccine: Human Papillomavirus Vaccine. I have no disclosures.

An update on the Human Papillomavirus Vaccines. I have no financial conflicts of interest. Case 1. Objectives 10/26/2016

You are the Key to HPV Cancer Prevention

Disclosures. You are the Key to HPV Cancer Prevention

HPV Vaccination: A Missed Opportunity for Cancer Prevention. New Developments in Objectives for today s talk

Advancing HPV Vaccination in Your Practice Jane Pezua, MPH Health Educator Adolescent Immunization Coordinator

De-Sexualizing the HPV Vaccine How to Counsel Your Families

Increasing HPV Vaccination Rates in NYS. Jim Kirkwood NYSDOH, Bureau of Immunization

Disclosures. New ACIP Recommendations for HPV Vaccination. Human Papillomaviruses. Objectives

Human Papillomavirus Lafayette Medical Education Foundation June 19, 2018

HPV Vaccine Ina Park, MD, MS

Update on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017

2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS

2017 HPV Vaccine Update HPV 2-Dose Schedule Recs Adult Coalition Meeting January 11, 2017

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV?

Adolescent Immunizations

HPV Vaccination. Steps for Increasing. in Practice. An Action Guide to Implement Evidence-based Strategies for Clinicians*

A Vaccine to Prevent Cancer: the Moral Imperative to Improve HPV Vaccination Rates

A Vaccine to Prevent Cancer: the Moral Imperative to Improve HPV Vaccination Rates

REACHING OUR GOALS: IMMUNIZATION PROVIDER EDUCATION

Immunise against HPV

HPV in the U.S.- Where are we now?

YOU ARE THE KEY Strategies to Improve HPV Vaccination Rates

Health Cognition & Behavior Lab

The HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland

Recommended vaccines in the United States. Maki Kano, MD September 23, 2017 Apple Time

Immunization Update: What s New?

YOU ARE THE KEY. July 11, 2014

CFM Grand Rounds Continuing Education

Communicating about HPV vaccination: Lessons learned from physicians and parents

What You Should Know. Exploring the Link between HPV and Cancer.

STATE IMMUNIZATION UPDATE Pejman Talebian, Director Immunization Program Rebecca Vanucci, Immunization Outreach Coordinator, Immunization Program

Understanding the HPV Vaccine and Patient Follow-Through

HPV Trends: Improving Vaccination Coverage

7 10 YEARS YEARS YEARS

Questions and answers about HPV. Facts about the virus and the vaccine

SCCPS Scientific Committee Position Paper on HPV Vaccination

Welcome to the California Immunization Coalition Education Hour

Protecting Our Children: 2015 Summit on HPV-Related Diseases Epidemic of HPV Cancers in Men: What Can We Do Now? June 18, 2015; Houston, Texas

Human Papillomavirus Immunisation Programme. Background

2017 Vaccination Update

Three Cs Confident, Concise and Consistent Health Care Provider Recommendations and FAQs. Three Cs Recommendation and FAQs

Guard Ur Self: HPV and Immunization Education

Hosting a Film Viewing Guide

HPV doesn t concern men?

Immunization Update 2015

Strategies for Improving HPV Vaccination Coverage Rates & Motivating Diverse Partners

HPV WHAT YOU SHOULD KNOW ABOUT HPV, CERVICAL CANCER, AND GENITAL WARTS. CERVICAL CANCER IS CAUSED BY CERTAIN TYPES OF A VIRUS.

Preventive Vaccines against HPV. Paris, 2 April 2015 Yvonne Deleré, MD (former) Immunization Unit, Robert Koch Institute, Berlin

Natoshia M. Askelson, MPH, PhD Elizabeth T. Momany, PhD Mesay Tegegne Stephanie Edmonds, RN, MPH

Immunization Update. William Atkinson, MD, MPH. Immunization Action Coalition

PROGRAM PRACTICES SUBMISSION FORM

Learning Objectives 12/9/2015. HPV Vaccine and Provider Parent Communication REFRAMING THE HPV VACCINE JUST ANOTHER SHOT:

Alaska Statewide Maternal Child Health & Immunization Conference. Doreen Stangel Lorraine Alfsen September 23, 2008

your 11- to 13-year-old and enter a raffle to win a Nintendo Wii and other great prizes visit: for more information

Immunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H.

Comparison of immunogenicity of 2-dose and 3-dose regimens of 9-valent HPV vaccine Advisory Committee on Immunization Practices 24-Feb-2016

Update on Anal HPV. Medical Management of AIDS. December 9, Joel Palefsky Department of Medicine University of California, San Francisco

71272GPeducation_03: Intervention Tools

Immunization Update 2015

Sharon G. Humiston, MD, MPH, FAAP Professor of Pediatrics Children s Mercy Hospital Kansas City, MO

Faculty Disclosure. Kerry Kernen, MPA, MSN, RN

Make the CASE FOR PHARMACISTS ONLY. Helpful information for talking to parents about HPV vaccination

3/2/2017. The School Nurse Role In Human Papillomavirus Vaccine Series Completion OBJECTIVES

HPV and Cervical Cancer: Current Practice Update

Transcription:

You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Successfully Communicating about HPV Vaccination

Disclosure This presentation is funded through the National AHEC Organization through a cooperative agreement.

Objectives 1. Define the importance of HPV vaccination for cancer prevention and the rationale for vaccinating at ages 11 or 12. 2. List the recommendations for HPV vaccine for girls and for boys. 3. Provide useful and compelling information about HPV vaccine to parents to aid in making the decision to vaccinate. 4. Locate resources relevant to current immunization practice.

Understanding the Burden HPV INFECTION & DISEASE

HPV Infection Most females and males will be infected with at least one type of mucosal HPV at some point in their lives Estimated 79 million Americans currently infected 14 million new infections/year in the US HPV infection is most common in people in their teens and early 20s Most people will never know that they have been infected Jemal A et al. J Natl Cancer Inst 2013;105:175-201

New Cancers Caused by HPV per Year Vagina n=600 3% Oropharynx n=1,800 10% United States 2006-2010 Vulva n=2,200 13% Anus n=2,600 15% Cervix n=10,400 59% Penis n=700 8% Anus n=1,400 15% Oropharynx n=7,200 77% Women (n = 17,600) Men (n = 9,300) CDC, United States Cancer Statistics (USCS), 2006-2010

Without vaccination, annual burden of genital HPV-related disease in U.S. females: 4,000 cervical cancer deaths 10,846 new cases of cervical cancer 330,000 new cases of HSIL: CIN2/3 (high grade cervical dysplasia) 1 million new cases of genital warts 1.4 million new cases of LSIL: CIN1 (low grade cervical dysplasia) Nearly 3 million cases and $7 billion American Cancer Society. 2008; Schiffman Arch Pathol Lab Med. 2003; Koshiol Sex Transm Dis. 2004; Insinga, Pharmacoeconomics, 2005

Evidence-Based HPV Disease Prevention HPV VACCINE

HPV Vaccine Recommendation Girls & Boys can start HPV vaccination at age 9 Preteens should finish HPV vaccine series by 13 th birthday Plus girls 13-26 years old who haven t started or finished HPV vaccine series Plus boys 13-21 years old who haven t started or finished HPV vaccine series

HPV Vaccine Comparison These Genital warts ~66% of ~15% of HPV Types Cervical Cervical Cause: Cancers Cancers

Updated ACIP Recommendations Age Routine vaccination at age 11 or 12 years* Vaccination recommended through age 26 for females and through age 21 for males not previously vaccinated Vaccination recommended for men through age 26 who have sex with men (MSM) or are immunocompromised (including persons HIV-infected) Formulation by gender (assuming availability) 9vHPV 4vHPV 2vHPV Females Males *vaccination series can be started at 9 years of age MMWR 2015;64:300-4 11

Updated ACIP Recommendations: Interchangeability If vaccination providers do not know, or do not have available the HPV vaccine product previously administered, or are in settings transitioning to 9vHPV: For protection against HPV 16 and 18, Females: Any HPV vaccine product may be used to continue or complete the series Males: 4vHPV or 9vHPV may be used to continue or complete the series MMWR 2015;64:300-4 12

ACIP Recommendations: Timing of the Series 2vHPV, 4vHPV and 9vHPV are each administered in a 3-dose schedule Interval between doses 1 2: Interval between doses 1 3: ~6 weeks (1-2 months) 6 months If the vaccine schedule is interrupted, the series does not need to be restarted MMWR 2015;64:300-4 13

HPV VACCINE SAFETY

VAERS: HPV Vaccine Safety Monitoring Ongoing safety monitoring has shown most reports are non-serious Among the 7.6% of reports coded as serious, most frequently cited possible side effects are headache, nausea, vomiting, and fever Syncope (fainting) continues to be reported following vaccination among adolescents Adherence to a 15-minute observation period after vaccination is encouraged MMWR. 2014;63(RR05);1-30. 1

9vHPV Vaccine Safety Seven pre-licensure studies including 15,000 males and females Generally well tolerated Adverse event profile similar to that of 4vHPV across age, gender, race, and ethnicity More injection-site reactions expected among those who receive 9vHPV

Monitoring Impact of HPV Vaccine Programs on HPV-Associated Outcomes HPV VACCINE IMPACT

HPV vaccine impact monitoring Post licensure evaluations are important to evaluate real world effectiveness of vaccines Population impact against early and mid outcomes have been reported: Genital warts Australia, New Zealand, Denmark, Sweden, Germany, Quebec, US HPV prevalence Australia, Norway, Denmark, Sweden, UK, US Cervical lesions Australia, British Columbia, Denmark, Sweden, US 18

HPV Vaccine Duration of Immunity Studies suggest that vaccine protection is long-lasting; no evidence of waning immunity Available evidence indicates protection for at least 8-10 years Multiple cohort studies are in progress to monitor the duration of immunity

HPV Vaccine Three-Dose Coverage Among Girls in High-Income Countries United States HPV VACCINE COVERAGE

Adolescent Vaccination Coverage United States, 2006-2014 100 Revised APD Definition 90 87.6 80 79.3 70 Percent Vaccinated 60 50 40 30 60 41.7 39.7 Tdap MCV4 1 HPV girls 3 HPV girls 1HPV boys 20 21.6 3 HPV boys 10 0 2006 2007 2008 2009 2010 2011 2012 2013 2014 Survey Year

Impact of Eliminating Missed Opportunities by Age 13 Years in Girls Born in 2000 100 Percent Vaccinated 80 60 40 20 47 91 Actual Achievable 0 HPV-1 (girls) Vaccine Missed opportunity: Healthcare encounter when some, but not all ACIP-recommended vaccines are given. HPV-1: Receipt of at least one dose of HPV. MMWR. 63(29);620-624.

Talking about HPV vaccine FRAMING THE CONVERSATION

Clinicians Underestimate the Value Parents Place on HPV Vaccine Median Values 10 9 8 7 6 5 4 3 2 1 0 Parent Provider's estimate 9.4 9.2 9.5 9.2 9.5 9.3 9.3 9.3 9.2 Meningitis Hepatitis Pertussis Influenza HPV Adolescent vaccines 7.0 5.2 7.8 Adapted from Healy et al. Vaccine. 2014;32:579-584.

A strong recommendation from you is the main reason parents decide to vaccinate Many moms in focus groups stated that they trust their child s doctor and would get the vaccine for their child as long as they received a recommendation from the doctor MMWR 2014; 63(29);625-633; Unpublished CDC data, 2013. Give a Strong Recommendation to Receive HPV Vaccine at Ages 11 or 12 Not sexually active Not recommended Safety concern/side effects Not needed or necessary Lack of knowledge 0 5 10 15 20 Percent

Make an Effective Recommendation Same way: Effective recommendations group all of the adolescent vaccines Recommend HPV vaccination the same way you recommend Tdap & meningococcal vaccines. Same day: Recommend HPV vaccine today Recommend HPV vaccination the same day you recommend Tdap & meningococcal vaccines. Unpublished CDC data, 2013.

Clinicians can give a strong and effective HPV vaccine recommendation by announcing: Sophia is due for three vaccines today. These will help protect her from meningitis, HPV cancers, and pertussis. We ll give those shots at the end of the visit.

If main concern is Why does my child need this vaccine try saying: HPV vaccine is very important because it prevents cancer. I know we d like to protect Maureen from cancer and I d feel better if she got her first dose of the HPV vaccine series today.

If main concern is My daughter will wait for marriage/won t be exposed, try saying: HPV is so common that almost everyone will be infected at some time. When your daughter marries, she could catch HPV from her husband. He might have been infected before he ever met her.

If main concern is why now, let s wait until child is older, try saying: HPV vaccine produces a more robust immune response in preteens than in older teens which is why I recommend starting the HPV vaccine series today.

If main concern is would you give it to your child, try saying: Yes, I gave it to my child (or grandchild, etc) because I think preventing cancer is very important.

If main concern is side effects, try saying: Vaccines, like any medication, can cause side effects. With HPV vaccine most are mild, primarily pain or redness in the arm. This should go away quickly. HPV vaccine has not been linked with any serious or long-term side effects.

Before leaving the exam room, remind parents when to come back. Try saying: To work, Robert needs the full HPV vaccine series, so... Please make sure to make appointments for the next shot on the way out, and put that appointment on your calendar before you leave the office today!

HPV VACCINE IS CANCER PREVENTION And YOU are the key! #WeCanStopHPV